Response to letter: limitations of human papillomavirus DNA testing in measuring previous exposure and vaccine protection

Sadlier C.; Sheils O.; Bergin C.

首页> 外文期刊>HIV medicine >Response to letter: limitations of human papillomavirus DNA testing in measuring previous exposure and vaccine protection

【24h】

Response to letter: limitations of human papillomavirus DNA testing in measuring previous exposure and vaccine protection

机译：来信答复：人乳头瘤病毒DNA检测在测量以前的暴露和疫苗保护方面的局限性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《HIV medicine》 |2016年第7期|共2页
作者
Sadlier C.; Sheils O.; Bergin C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Response to letter: limitations of human papillomavirus DNA testing in measuring previous exposure and vaccine protection [J] . Sadlier C., Sheils O., Bergin C. HIV medicine . 2016,第7期

机译：来信答复：人乳头瘤病毒DNA检测在测量以前的暴露和疫苗保护方面的局限性
2. Response to letter: limitations of human papillomavirus DNA testing in measuring previous exposure and vaccine protection [J] . Sadlier C., Sheils O., Bergin C. HIV medicine . 2016,第7期

机译：回应字母：利用人乳头瘤病毒DNA检测测量以前暴露和疫苗保护的局限性
3. Limitations of human papillomavirus DNA testing in measuring previous exposure and vaccine protection [J] . Brown B. HIV medicine . 2015,第7期

机译：人类乳头瘤病毒DNA检测在检测以前的暴露和疫苗保护方面的局限性
4. DIFFERENTIAL ANTIBODY RESPONSE AGAINST CONFORMATIONAL AND LINEAR EPITOPES OF THE L1 PROTEIN FROM HUMAN PAPILLOMAVIRUS TYPES 16/18 IS GENERATED IN VACCINATED WOMAN OR WITH DIFFERENT EXPOSURES TO THE VIRUS. [C] . Gutierrez-Xicotencatl L, Pedroza-Saavedra A, Rodriguez-Ocampo AN, Vaccine technology VI . 2016

机译：针对人乳头瘤病毒类型16/18的L1蛋白质的构象和线性表位产生的不同抗体反应是在疫苗接种的妇女中产生的，或在与病毒的不同接触中产生的。
5. Prevention of human papillomavirus (HPV) infection and HPV-related diseases: Barriers to HPV vaccine coverage among university women in the U.S., and Initial steps in integrating cervical cytology testing into primary care in the Republic of Georgia. [D] . Bednarczyk, Robert A. 2010

机译：预防人乳头瘤病毒（HPV）感染和与HPV相关的疾病：美国大学女性中HPV疫苗覆盖率的障碍，以及在佐治亚州将宫颈细胞学检测纳入初级保健的初始步骤。
6. Letter-to-the-Editor in response to “Tanton C, et al. Human papillomavirus (HPV) in young women in Britain: Population-based evidence ofthe effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types. Papillomavirus Res. 2017 Jun;3:36-41.doi: 10.1016/j.pvr.2017.01.001.” [O] . Martin Ryser, Adrienne Guignard, Valérie Berlaimont 2012

机译：致编辑的信，回应“ Tanton C等人。英国年轻女性中的人乳头瘤病毒（HPV）：基于人群的二价免疫计划有效性以及四价和9价疫苗类型负担的证据。乳头瘤病毒Res。 2017年6月； 3：36-41.doi：10.1016 / j.pvr.2017.01.001。”
7. Response to letter: limitations of human papillomavirus DNA testing in measuring previous exposure and vaccine protection [O] . C Sadlier, O Sheils, C Bergin 2016

机译：回应字母：利用人乳头瘤病毒DNA检测测量在测量之前的暴露和疫苗保护中的局限性
8. Boosting of DNA Vaccine-Elicited Gamma Interferon Responses in Humans by Exposure to Malaria Parasites [R] . Wang, R. , Richie, T. L. , Baraceros, M. F. , 2004

机译：通过暴露于疟疾寄生虫引发DNa疫苗引发人类γ干扰素反应

Response to letter: limitations of human papillomavirus DNA testing in measuring previous exposure and vaccine protection

著录项

相似文献

相关主题

期刊订阅